LarotrectinibLack of efficacy following compassionate use: 2 case reports

被引：0

|

作者：

机构：

来源：

Reactions Weekly | 2021年 / 1883卷 / 1期

关键词：

D O I：

10.1007/s40278-021-06176-8

中图分类号：

学科分类号：

摘要：

引用

收藏

页码：221 / 221

相关论文

共 50 条

[21] Decitabine/deoxythymidineDiarrhoea and elevation of transaminase following compassionate use: 4 case reports
Reactions Weekly, 2019, 1766 (1) : 117 - 117
[22] Elexacaftor/ivacaftor/tezacaftorVarious toxicities following compassionate use: 9 case reports
Reactions Weekly, 2025, 2045 (1) : 150 - 150
[23] Azithromycin/remdesivirHepatotoxicity following compassionate use and lack of efficacy: case report
Reactions Weekly, 2022, 1933 (1) : 109 - 109
[24] Oxaliplatin/topotecan/vincristineVarious toxicities following compassionate use: 12 case reports
Reactions Weekly, 2020, 1802 (1) : 233 - 233
[25] Inotuzumab-ozogamicinVarious toxicities following compassionate use: 10 case reports
Reactions Weekly, 2020, 1815 (1) : 169 - 169
[26] OmalizumabLack of efficacy following off label use: 2 case reports
Reactions Weekly, 2022, 1909 (1) : 440 - 440
[27] DexamethasoneLack of efficacy following off label use: 2 case reports
Reactions Weekly, 2023, 1960 (1) : 162 - 162
[28] AntineoplasticsVarious toxicities, drug resistance/lack of efficacy and compassionate use: 4 case reports
Reactions Weekly, 2022, 1920 (1) : 69 - 69
[29] Bamlanivimab/dexamethasoneLack of efficacy following off label use: 2 case reports
Reactions Weekly, 2022, 1933 (1) : 110 - 110
[30] OctreotideLack of efficacy following off-label use: 2 case reports
Reactions Weekly, 2021, 1859 (1) : 288 - 288

← 1 2 3 4 5 →